Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 834 results for "mylan"

UPDATE: Morgan Stanley Resumes Coverage On Mylan As Attractive...

In a report published Thursday, Morgan Stanley analyst David Risinger resumed coverage on Mylan Inc. (NASDAQ: MYL) with an Overweight rating and $67.00 price target. In the report, Morgan Stanley noted, "We believe Mylan's depressed multiple is an ..., 14 hours ago

117 images for mylan

BioSpace, 2 days ago
Yahoo! Finance, 2 days ago
One News Page United Kingdom, 2 days ago
Pharma Letter, 2 days ago, 2 days ago
PR Newswire, 2 days ago
MedIndia, 1 week ago
Drug Discovery and Development, 3 days ago
Merced Sun-Star, 3 days ago
Modesto Bee, 3 days ago

Mylan Q4 Adj Profit Meets View, Revenues Top; Guides 2015 In Line

Generic drugmaker Mylan, Inc. (MYL: Quote) reported Monday a profit for the fourth quarter that grew percent from last year, reflecting improved margins and double-digit revenue growth. Adjusted earnings per share matched analysts' expectations, ...
 RTTNews.com3 days ago Mylan Guides In-line  Individual.com3 days ago Mylan Q4 Profit Meets Estimate  RTTNews.com3 days ago Financial Report: Mylan  Contract Pharma2 days ago
FDA News

Branded Sovaldi to Debut in India in Coming Months, Distributed by Mylan Subsidiary

The branded version of Gilead's pricey blockbuster hepatitis C therapy Sovaldi is expected on Indian pharmacy shelves in the second quarter of this year, distributed under an exclusive licensing agreement with Mylan's Indian subsidiary. In ...
 FDA News3 days ago Mylan enters into distribution agreement with Gilead for hepatitis C drug  Individual.com1 week ago Mylan to distribute Gilead Sciences' hep C drugs, Sovaldi & Harvoni in India  PharmaBiz1 week ago Mylan Soon to Distribute Hepatitis C Drugs in India  Med India1 week ago
Vision Monday

Mylan acquires markets specialty and branded generics business of Abbott Laboratories

Mylan, Inc., a pharmaceutical company, has acquired the markets specialty and branded generics business (Assets) from Abbott Laboratories, a healthcare company, in an all-stock transaction for approximately $5,300 million. Both the companies are ...
 Individual.com3 days ago Mylan N.V. and Mylan Inc. Announce Commencement of Consent Solicitations for Mylan Inc.'s Notes  Vision Monday2 days ago Abbott Laboratories : Mylan completes inversion with Abbott to move headquarters to Netherlands, lower taxes  4 Traders2 days ago Mylan Guides In-line  Earnings Whispers3 days ago
New Indian Express

A Revolution of Happy Smiles

BENGALURU: Smile Pinki (2008) was a 39-minute documentary directed by Megan Mylan and the film narrated the story of a cleft lipped girl whose life is transformed when she receives free surgery. The documentary was made in Hindi and Bhojpuri, and ...
 New Indian Express2 days ago
India Infoline

Udbhav Ganjoo quits Ranbaxy, may join Mylan

Read more on: Health/Medical/Pharmaceuticals | Mylan Inc. | Ranbaxy Laboratories | Udbhav Ganjoo Udbhav Ganjoo, the global Head of Human Resources Ranbaxy Laboratories, has resigned from the company and may join multinational ...
 EHealth Magazine2 days ago Ranbaxy's global HR head Udbhav Ganjoo quits, may join Mylan: Sources  Economic Times3 days ago Ranbaxy Lab global HR head Udbhav Ganjoo quits  India Infoline3 days ago

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute SovaldiĀ® and HarvoniĀ® in India

By a News Reporter-Staff News Editor at AIDS Weekly -- Mylan Inc. (Nasdaq: MYL) announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited , has entered into an agreement with Gilead Sciences , under which Mylan has been appointed ...
 4 Traders1 day ago
The Telegraph

US drugmaker Mylan to acquire Famy Care for $750 Million

ureau | 3 Feb, 2015, 05.26AM IST Post a Comment MUMBAI: Mylan, the world's second biggest generic drugs maker, will pay $750 million or about Rs 4,944 crore to buy the women's health business of Mumbai-based Famy Care and expand its presence in the market for ...
 Economic Times1 month ago Mylan in buy mode  The Telegraph1 month ago Mylan buys Famy Care's contraceptive biz for $800m  Times of India1 month ago Mylan Inc to acquire Famy Care's certain biz for USD 800 mn  Business Standard1 month ago
Business Standard

Natco Pharma's US partner Mylan files application with USFDA

Drug firm Natco Pharma's marketing partner Mylan Inc has filed an application with the US health regulator for generic Sorafenib tablets used mainly for treatment of liver and kidney cancers. The company's marketing partner Mylan Inc has filed an ...
 Business Standard3 weeks ago Natco Pharma's partner Mylan files application for Sorafenib with the USFDA  Business Standard3 weeks ago
Business Standard

Mylan expands hepatitis-C agreement with Gilead

Drug could become the first all-oral single tablet regimen for all hepatitis-C genotypes BS Reporter | Hyderabad January 27, 2015 Last Updated at 20:41 IST US generics pharmaceuticals maker Mylan Inc today said that its subsidiary Mylan Laboratories Limited, ...
 Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less